Cash payment to holders of outstanding equity awards for settlement of such vested and non-vested awards Cash Transferred for Outstanding Equity Awards for Settlement of Vested and Non-Vested Awards The fair value, at acquisition date, of cash transferred for outstanding equity awards for settlement of vested and non-vested awards as consideration in a business combination. Amounts which may be re-classified to the income statement: Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Restricted cash balances for funds held in escrow Current restricted cash and cash equivalents Disclosure of contingent liabilities [line items] Disclosure of contingent liabilities [line items] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Classes of intangible assets other than goodwill [domain] Classes of intangible assets other than goodwill [domain] Schedule of finance income and expenses Disclosure Of Finance Income Expenses [Table Text Block] na Investment in tangible assets Purchase of property, plant and equipment, classified as investing activities Share-based compensation expense Adjustments for share-based payments Translation reserves Reserve of exchange differences on translation [member] Classes of intangible assets and goodwill [axis] Classes of intangible assets and goodwill [axis] Disclosure of detailed information about business combination [line items] Disclosure of detailed information about business combination [line items] Levels of fair value hierarchy [domain] Levels of fair value hierarchy [domain] Total costs and operating expenses Operating expense Withholding taxes on behalf of employees on net settled RSUs Decrease (increase) through tax on share-based payment transactions, equity Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Operating Capital Royalties by Product [Axis] Royalties by Product [Axis] Information by royalties by product. Warrants Warrants [member] Schedule of level 3 reconciliation of assets Disclosure Of Fair Value Measurement Of Assets, Level 3 Reconciliation [Table Text Block] Tabular disclosure of level 3 reconciliation of assets measured at fair value. Schedule of intangible assets and goodwill Disclosure of reconciliation of changes in intangible assets and goodwill [text block] Other investments Investments accounted for using equity method All Currencies [Domain] All Currencies [Domain] Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of detailed information about financial instruments [abstract] Disclosure of detailed information about financial instruments [abstract] Cash and cash equivalents include: Cash and cash equivalents [abstract] Non-current deferred tax liability Deferred tax liabilities recognised as of acquisition date Schedule of fair value changes on Level 3 investments of assets Disclosure of fair value measurement of assets [text block] Total shareholders' equity Balance at beginning of period Balance at end of period Total shareholders' equity Equity Disclosure of transactions between related parties [line items] Disclosure of transactions between related parties [line items] Disclosure of fair value measurement of assets [line items] Disclosure of fair value measurement of assets [line items] Amortization Amortisation expense Other comprehensive income: Other comprehensive income [abstract] Number of independent board members Number of Independent Board Members Number of independent board members. Property and equipment Property, plant and equipment Net financial items Finance income (cost) Disclosure of transactions between related parties [abstract] Mijke Zachariasse, Martin Schultz and Michael Kavanagh Mijke Zachariasse, Martin Schultz And Michael Kavanagh [Member] Represents information pertaining to Mijke Zachariasse, Martin Schultz and Takahiro Hamatani. RSUs vested (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Elizabeth O’Farrell, Paolo Paoletti and Anders Gersel Pedersen Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Elizabeth O’Farrell, Paolo Paoletti and Anders Gersel Pedersen [Member] Represents information pertaining to Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Dr. Paolo Paoletti, and Dr. Anders Gersel Pedersen. Intangible assets and goodwill at beginning of period Intangible assets and goodwill at end of period Intangible assets and goodwill Consolidated Statements of Changes in Equity Statement of changes in equity [line items] Classes of contingent liabilities [domain] Classes of contingent liabilities [domain] Exchange differences on translation of foreign operations Other comprehensive income, before tax, exchange differences on translation of foreign operations Other investments bought Purchase of interests in investments accounted for using equity method Financial income Total financial income Finance income Level 1 Level 1 of fair value hierarchy [member] Interest elements of lease payments Adjustments For Interest On Lease Payments Adjustments for interest on lease payments to reconcile profit (loss) to net cash flow from (used in) operating activities. Disclosure of detailed information about changes in presentation currency Disclosure Of Detailed Information About Changes in Presentation Currency [Table Text Block] Disclosure Of Detailed Information About Changes in Presentation Currency Re-election to the board of directors, term Re-Election to the Board of Directors, Term The term limit of board of directors who are re-elected. Acquisition of business, net of cash acquired Cash used for acquisition of business Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities % change in share capital - warrants exercised Percentage Of Share Capital Attributed To Exercise Of Warrants Percentage of share capital attributed by exercise of warrants which increase the share capital. Transactions with owners: Transactions With Owners [Abstract] n/a Level 2 Level 2 of fair value hierarchy [member] Disclosure of non-adjusting events after reporting period [abstract] Additions during the period Acquisitions through business combinations, intangible assets and goodwill AbbVie AbbVie [Member] This member stands for collaboration arrangement with Abbvie. Litigation Case [Axis] Litigation Case [Axis] Other non-current assets Other Non-Current Assets Recognised As Of Acquisition Date The amount recognised as of the acquisition date for other non-current assets acquired in a business combination. Total lease liabilities Lease liabilities Effect of exchange rate adjustment Increase (decrease) through net exchange differences, intangible assets and goodwill Purchase of treasury shares Payments To Acquire Treasury Shares The cash outflow to acquire treasury shares. Share premium Share premium [member] Statement of financial position [abstract] Disclosure of contingent liabilities [abstract] Schedule of revenue by type, collaboration partner, and product under agreements. Disclosure of disaggregation of revenue from contracts with customers [text block] Cover [Abstract] Maximum Maximum [Member] Weighted average exercise price per warrant granted (in DKK per share) Weighted Average Exercise Price Of Warrants Granted Exercise price per share or per unit of warrants granted during the period. DKK Denmark, Kroner Summary of RSUs activity Disclosure of number and weighted average exercise prices of other equity instruments [text block] Acquisitions Purchases, fair value measurement, assets Total liabilities Total liabilities Liabilities Financial expenses: Financial Expenses [Abstract] na Total current liabilities Current liabilities Properties Properties [Member] Represents information pertaining to properties. Classes of intangible assets other than goodwill [axis] Classes of intangible assets other than goodwill [axis] Share capital Issued capital Collaboration revenue Collaboration Revenue [Member] This member stands for collaboration revenue. Other Intangible Assets and Goodwill Disclosure of intangible assets and goodwill [text block] Number of shares authorized for repurchase (in shares) Number Of Shares Authorized To Be Repurchased The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. Transfers into Level 3 of fair value hierarchy, assets Transfers into Level 3 of fair value hierarchy, assets Collaborative Arrangement and Arrangement Other Than Collaborative [Domain] Collaborative Arrangement and Arrangement Other Than Collaborative [Domain] Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. Inventories Current inventories Share premium Share premium Cash flows from financing activities Cash flows from (used in) financing activities [abstract] Corporate tax payable Current tax liabilities, current Statement of profit or loss and other comprehensive income [abstract] Other Other Royalty Products [Member] Other Royalty Products Disclosure of quantitative information about right-of-use assets [line items] Disclosure of quantitative information about right-of-use assets [line items] Other current assets Other Current Assets Recognised As Of Acquisition Date The amount recognised as of the acquisition date for other current assets acquired in a business combination. Opening balance before adjustment, cumulative effect at date of initial application [member] Opening balance before adjustment, cumulative effect at date of initial application [member] Amount of provision recorded Other provisions Total comprehensive income Comprehensive income Comprehensive income Gain on other investments, net Gain (Loss) On Other Investments, Net The gains on other investments. Statement of changes in equity [abstract] Retained earnings Retained earnings Corporate tax Tax expense (income) Schedule of details of acquisition Disclosure of detailed information about business combination [text block] Subsequent Events to the Balance Sheet Date Disclosure of events after reporting period [text block] Basis of Presentation Disclosure of basis of preparation of financial statements [text block] Disclosure of detailed information about exchange rates explanatory Disclosure Of Detailed Information About Exchange Rates Explanatory [Table Text Block] Disclosure Of Detailed Information About Exchange Rates Explanatory Cash flows from operating activities Cash flows from (used in) operating activities [abstract] Document Fiscal Period Focus Document Fiscal Period Focus Total assets Total assets Assets RSUs granted (in shares) Number of other equity instruments granted in share-based payment arrangement Selling, general and administrative expenses Selling, general and administrative expense Document Period End Date Document Period End Date Litigation Case [Domain] Litigation Case [Domain] Types of risks [domain] Types of risks [domain] Number of share buy back programs Number of Share Buy Back Programs Number of shares initiated on buy-back programs. Triple A-Rating Triple A-Rating [Member] This member stands for Triple A-rating. Receivables Adjustments for decrease (increase) in trade and other receivables Credit risk Credit risk [member] Intangible assets and goodwill [abstract] Research and development expenses Research and development expense Gain on marketable securities Gains On Marketable Securities The gains on marketable securities. Goodwill Goodwill Revenue Revenue Warrants granted (in shares) Number Of Warrants Granted During Period The number of warrants granted during period. Foreign exchange rate gain Foreign exchange rate gain Net foreign exchange gain Document Type Document Type Share repurchase, percentage of share capital authorized Share Repurchase, Percentage of Share Capital Authorized Share Repurchase, Percentage of Share Capital Authorized Collaborative Arrangement and Arrangement Other Than Collaborative [Axis] Collaborative Arrangement and Arrangement Other Than Collaborative [Axis] Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. TEPEZZA TEPEZZA [Member] This member stands for TEPEZZA. Share capital Issued capital [member] Classes of financial assets [axis] Classes of financial assets [axis] Cumulative effect at date of initial application [axis] Cumulative effect at date of initial application [axis] Interest and other financial income Interest And Other Financial Income The interest and other financial income. Cash paid for outstanding shares Cash Transferred for Outstanding Shares The fair value, at acquisition date, of cash transferred for outstanding shares as consideration in a business combination. Financial income Adjustments for finance income Chugai Patent Infringement Complaint Chugai Patent Infringement Complaint [Member] Chugai Patent Infringement Complaint Share repurchase, percentage of purchase price deviation Share Repurchase, Percentage Of Purchase Price Deviation From Quoted Price Share Repurchase, Percentage Of Purchase Price Deviation From Quoted Price Profit or loss [abstract] Profit or loss [abstract] Contract liabilities Current contract liabilities Lease liabilities Non-current Non-current lease liabilities Summary of warrants activity Disclosure Of Warrants Activity [Table Text Block] Tabular disclosure of warrants activity. Disclosure of quantitative information about right-of-use assets [table] Disclosure of quantitative information about right-of-use assets [table] Weighted average Black-Scholes fair value per warrant granted (in DKK per share) Weighted Average Exercise Price Of Fair Value Of Warrants Exercise price per share or per unit of fair value of warrants during the period. Revenue Revenue of combined entity as if combination occurred at beginning of period Revenue Disclosure of revenue from contracts with customers [text block] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Classes of assets [axis] Classes of assets [axis] Summary of statement of comprehensive income amounts relating to leases Summary of statement of comprehensive income amounts relating to leases [Table Text Block] Tabular disclosure of comprehensive information relating to leases. Other intangible assets Intangible assets other than goodwill Types of share-based payment arrangements [domain] Types of share-based payment arrangements [domain] Disclosure of fair value measurement of assets [table] Disclosure of fair value measurement of assets [table] Revenue Revenue of acquiree since acquisition date Currency risk Currency risk [member] Range [axis] Range [axis] IPR&D Acquired IPR&D In Process Research and Development [Member] In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process. Disclosure of reconciliation of changes in intangible assets and goodwill [abstract] Disclosure of reconciliation of changes in intangible assets and goodwill [abstract] Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash and cash equivalents Components of equity [axis] Components of equity [axis] RSUs Restricted share units [member] Marketable securities sold Proceeds from sales of investments other than investments accounted for using equity method Deferred tax liabilities Deferred tax liabilities Technology platform intangible asset Technology Platform Technology-based intangible assets [member] Net profit before tax Net profit before tax Profit (loss) before tax Net product sales Net Product Sales [Member] Net Product Sales Other comprehensive income Other comprehensive income ASSETS Assets [abstract] Transfers out of Level 3 of fair value hierarchy, assets Transfers out of Level 3 of fair value hierarchy, assets Fair value changes Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets Other investments Other Investments1 [Member] Represents information pertaining to other investments. Total identifiable net assets Identifiable assets acquired (liabilities assumed) Total shareholders' equity and liabilities Equity and liabilities Change in cash and cash equivalents Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Business combinations [axis] Business combinations [axis] Percentage of share capital repurchased Percentage Of Share Capital Repurchased Percentage of share capital repurchased. External credit grades [axis] External credit grades [axis] Business combinations [domain] Business combinations [domain] Cash for equity compensation attributable to pre-combination service Cash Transferred for Outstanding Equity Awards for Settlement of Vested Awards The fair value, at acquisition date, of cash transferred for outstanding equity awards for settlement of vested awards where the vesting period was completed as consideration in a business combination. Schedule of fair value changes on Level 3 investments of liabilities Disclosure of fair value measurement of liabilities [text block] Other payables Other current payables Categories of related parties [domain] Categories of related parties [domain] Revenue [abstract] Revenue [abstract] Presentation of leases for lessee [abstract] Number of treasury shares cancelled Number Of Treasury Shares Cancelled Number Of Treasury Shares Cancelled Cash acquired Cash and cash equivalents Cash and cash equivalents recognised as of acquisition date Payment of withholding taxes on behalf of employees on net settled RSUs Payments Of Withholding Taxes On Behalf Of Employees On Net Settled RSUs The cash outflow for withholding taxes on behalf of employees on net settled restricted stock units (RSUs). Disclosure of detailed information about business combination [table] Disclosure of detailed information about business combination [table] Depreciation Adjustments for depreciation expense Weighted average exercise price on date of grant per warrant exercised (in DKK per share) Weighted Average Exercise Price Of Warrants Exercised Exercise price per share or per unit of warrants exercised during the period. Share capital reduction Share capital Reduction of issued capital Interest received Interest received, classified as operating activities Receivables Trade and other non-current receivables Treasury shares outstanding (in shares) Number of Treasury Shares Outstanding The number of shares that has been held in treasury. Foreign exchange rate loss Net foreign exchange loss Changes in fair value measurement, assets [abstract] Changes in fair value measurement, assets [abstract] USD United States of America, Dollars Roche Roche [Member] This member stands for collaboration arrangement with Roche. Contingent liability for guarantees Contingent liability for guarantees [member] Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Disclosure Of Detailed Information About Changes in Presentation Currency [Table] Disclosure Of Detailed Information About Changes in Presentation Currency [Table] Disclosure Of Detailed Information About Changes in Presentation Currency Bank deposits Cash Other reserves Other reserves BioNTech BioNTech [Member] This member stands for collaboration arrangements with BioNTech. Other Other Collaboration Partners [Member] Other Collaboration Partners Schedule of total marketable securities by currency Disclosure Of Marketable Securities By Currency [Table Text Block] Tabular disclosure of marketable securities in foreign currency. Cash flows from investing activities Cash flows from (used in) investing activities [abstract] Losses on marketable securities Loss on marketable securities Losses On Marketable Securities The losses on marketable securities. Short-term marketable securities Short-term investments, classified as cash equivalents Related Parties Disclosure of related party [text block] Classes of financial assets [domain] Classes of financial assets [domain] Basis of Presentation [Abstract] No definition available. Marketable securities Marketable Securities [Member] This member stands for marketable securities . Impairment losses for the period Impairment loss recognised in profit or loss, intangible assets and goodwill Board of directors, term Election to the Board of Directors, Term The term limit of board of directors. Classes of intangible assets and goodwill [domain] Classes of intangible assets and goodwill [domain] Net cash (used in) investing activities Investing activities Cash (used in) investing activities Cash flows from (used in) investing activities Kesimpta Kesimpta [Member] This member stands for Kesimpta. Level 3 Level 3 of fair value hierarchy [member] Cash flows from operating activities before financial items Cash Flow From (Used In) Operating Activities Before Financial Items The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities before reconciling the financial items. Share-based compensation expenses Increase (decrease) through share-based payment transactions, equity Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] DARZALEX DARZALEX [Member] This member stands for DARZALEX. Selling, general and administrative expenses Selling, General And Administrative Expenses of Acquiree The amount of selling, general and administrative expenses of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. Goodwill Goodwill recognised as of acquisition date Net cash (used in) financing activities Financing activities Cash flows from (used in) financing activities Lease liabilities Lease liabilities [abstract] Corporate tax receivable Corporate Tax Receivable Corporate Tax Receivable Number of business units Number Of Business Units Number Of Business Units Other payables Other non-current payables Amortization for the period Amortisation, intangible assets other than goodwill Acquisition related charges, equity awards related to post-combination sevices Cash Transferred For Outstanding Equity Awards For Settlement Of Non-Vested Awards The fair value, at acquisition date, of cash transferred for outstanding equity awards for settlement related to the portion of awards with future vesting conditions, and therefore attributable to post-combination services as consideration in a business combination. Total non-current assets Non-current assets Number of non independent board members Number of Non Independent Board Members Number of non independent board members. Total current assets Current assets Accumulated amortisation and impairment Accumulated depreciation, amortisation and impairment [member] Number of candidates Business Combination, Number of Candidates in Clinical Development, Rights Received Represents the number of candidates in clinical development for which received the rights. J&J J&J [Member] J&J Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Warrants exercised Proceeds from exercise of warrants Statement of changes in equity [table] Statement of changes in equity [table] AbbVie Rina-S Trade Secret Complaint AbbVie Rina-S Trade Secret Complaint [Member] AbbVie Rina-S Trade Secret Complaint Key management personnel of entity or parent Key management personnel of entity or parent [member] Total Expenses of Acquiree The amount of expenses of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. EUR Euro Member Countries, Euro Reimbursement revenue Reimbursement Revenue [Member] This member stands for reimbursement income. Goodwill Goodwill [member] Types of risks [axis] Types of risks [axis] Percentage of marketable securities Percentage of Marketable Securities The percentage of marketable securities. Other current liabilities Other Current Liabilities Recognised As Of Acquisition Date The amount recognised as of the acquisition date for other current liabilities acquired in a business combination. Exchange rate adjustments Effect of exchange rate changes on cash and cash equivalents Cost of product sales Cost of sales Classes of assets [domain] Classes of assets [domain] Net cash provided by operating activities Operating activities Cash flows from (used in) operating activities Impairment charges Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss Current Fiscal Year End Date Current Fiscal Year End Date Weighted average fair value per RSU granted (in DKK per share) Weighted Average Fair Value Of Other Equity Instruments Granted In Share-based Payment Arrangement The weighted average fair value of other equity instruments (i.e. other than share options) granted in a share-based payment arrangement. Disclosure of terms and conditions of share-based payment arrangement [line items] Disclosure of terms and conditions of share-based payment arrangement [line items] Types of revenues [axis] Types Of Revenues [Axis] The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table. Share-Based Payments Disclosure of share-based payment arrangements [text block] Disclosure of transactions between related parties [table] Disclosure of transactions between related parties [table] Contract liabilities Non-current contract liabilities Marketable securities bought Purchase of investments other than investments accounted for using equity method Document Fiscal Year Focus Document Fiscal Year Focus Receivables Trade and other current receivables Categories of related parties [axis] Categories of related parties [axis] Adjustments for non-cash transactions Adjustments to reconcile profit (loss) [abstract] Par value per share Par value per share Net profit Net profit Profit (loss) Deferred tax assets Net deferred tax assets Financial assets Fair value at beginning of period Fair value at end of period Financial assets Amendment Flag Amendment Flag Financial Instruments Disclosure of detailed information about financial instruments [text block] Components of equity Components of equity [domain] Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] Total non-current liabilities Non-current liabilities Property and equipment Property, plant and equipment recognised as of acquisition date ProfoundBio ProfoundBio [Member] This member stands for ProfoundBio. Closing rate Closing foreign exchange rate Financial expenses Total financial expenses Finance costs Number of employee elected board members Number of Employee Elected Board Members Number of employee elected board members. Number of patents Number Of Patents On Which The Case Filed Represents the number of patents on which the case is filed. Research and development expenses Research And Development Expenses of Acquiree The amount of research and development expenses of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. Corporate taxes paid Adjustments for income tax expense Financial Income and Expenses [Abstract] NA Disclosure of credit risk exposure [table] Disclosure of credit risk exposure [table] Contingencies Disclosure of contingent liabilities [text block] Warrants exercised (in shares) Number Of Warrants Exercised During Period The number of warrants exercised during period. Total depreciation charge of right-of-use assets Depreciation, right-of-use assets Number of shares acquired (in shares) Number Of Treasury Shares Acquired Number Of Treasury Shares Acquired Range [domain] Range [domain] Classes of contingent liabilities [axis] Classes of contingent liabilities [axis] Retained earnings Retained earnings [member] Types Of Revenues [Domain] Types Of Revenues [Domain] Types Of Revenues [Domain] Financial Income and Expenses Disclosure of finance income (cost) [text block] Disclosure of contingent liabilities [table] Disclosure of contingent liabilities [table] Summary of balance sheet amounts relating to leases Summary of balance sheet amounts relating to leases [Table Text Block] Tabular disclosure of balance sheet information relating to leases. Entity Central Index Key Entity Central Index Key Presentation currency change Increase (decrease) due to changes in accounting policy required by IFRSs [member] Disclosure of credit risk exposure [line items] Disclosure of credit risk exposure [line items] Excluding net product sales Excluding Net Product Sales [Member] Excluding Net Product Sales GBP United Kingdom, Pounds Pfizer Pfizer [Member] This member stands for Pfizer. Milestone revenue Milestone Revenue [Member] This member stands for revenue from milestone payments. Acquisition and integration related charges Acquisition and integration related charges Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination Share-based compensation expenses Expense from share-based payment transactions Exercise of warrants Increase (decrease) through exercise of warrants, equity Gross carrying value Gross carrying amount [member] Net Profit Profit (loss) of combined entity as if combination occurred at beginning of period SHAREHOLDERS’ EQUITY AND LIABILITIES Equity and liabilities [abstract] Revision of prior period, reclassification, adjustment Revision of Prior Period, Reclassification, Adjustment [Member] Other payables Adjustments for increase (decrease) in other liabilities Financial expenses Adjustments for finance costs External credit grades [domain] External credit grades [domain] Interest and other financial expenses Interest And Other Financial Expenses The interest and other financial expenses. Carrying amount [member] Carrying amount [member] Average rate Average foreign exchange rate Royalties Royalties [Member] This member stands for revenue form royalties. Lease liabilities Current Current lease liabilities Operating profit Profit (loss) from operating activities Licenses and Patents Licenses and Patents [Member] This member stands for a class of intangible assets representing licenses and patents. Intangible asset Identifiable intangible assets recognised as of acquisition date Business Combinations1 [Abstract] Business Combinations1 [Abstract] Business Combinations1 [Abstract] Currency [Axis] Currency [Axis] Inventories Adjustments for decrease (increase) in inventories Disclosure of terms and conditions of share-based payment arrangement [abstract] Diluted net profit per share (in dollars per share) Earnings per share - diluted (in DKK and US Dollars per share) Diluted earnings (loss) per share Total consideration Total consideration Consideration transferred, acquisition-date fair value Leases Disclosure of leases [text block] Principal elements of lease payments Payments of lease liabilities, classified as financing activities Right-of-use assets Total right-of-use assets Right-of-use assets Acquisition of Businesses Disclosure of business combinations [text block] Disclosure of terms and conditions of share-based payment arrangement [table] Disclosure of terms and conditions of share-based payment arrangement [table] Purchase of treasury shares Acquisition of treasury shares Purchase of treasury shares Royalties by Product [Domain] Royalties by Product [Domain] Information by royalties by product. Entity Registrant Name Entity Registrant Name Basic net profit per share (in dollars per share) Earnings per share - basic (in DKK and US Dollars per share) Basic earnings (loss) per share Disclosure Of Detailed Information About Changes in Presentation Currency [Line Items] Disclosure Of Detailed Information About Changes in Presentation Currency [Line Items] Disclosure Of Detailed Information About Changes in Presentation Currency Financial income: Financial Income [Abstract] na Investment in intangible assets Purchase of intangible assets, classified as investing activities Statement of cash flows [abstract] Novartis Novartis [Member] This member stands for collaborative arrangement with Novartis. Marketable securities Marketable Securities, Current Amount of investments in debt and equity securities which have original maturities over to 90 days, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.